Co-Managing Patients with Type 1 Diabetes and Cancer
- 20 June 2016
- journal article
- review article
- Published by Springer Nature in Current Diabetes Reports
- Vol. 16 (8) , 1-8
Abstract
The life expectancy of people with type 1 diabetes is improving and now approaches that of those without diabetes. As this population ages, a growing number will be diagnosed with and treated for cancer. Cancer treatments can drastically affect insulin requirement and glycemic control through multiple mechanisms including high doses of glucocorticoids and targeted therapies that directly interfere with cellular pathways involved in the action of insulin. Patients with cancer frequently also have alterations in gastrointestinal motility or appetite and require supplemental enteral or parenteral nutrition. Few studies have evaluated these patients directly, but data on patients with and without diabetes suggest that glycemic control may play a larger role in cancer outcomes than is often recognized. Collaboration between the treating oncologist and diabetologist allows people with diabetes to receive the most effective therapies for their cancers without undue risk of hypoglycemia or adverse outcomes due to hyperglycemia.Keywords
This publication has 64 references indexed in Scilit:
- Glucocorticoid-mediated BIM induction and apoptosis are regulated by Runx2 and c-Jun in leukemia cellsCell Death & Disease, 2012
- Mortality After Incident Cancer in People With and Without Type 2 DiabetesDiabetes Care, 2012
- A Prospective Study of the Associations Between Treated Diabetes and Cancer OutcomesDiabetes Care, 2011
- Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline UpdateJournal of Clinical Oncology, 2011
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific DeathNew England Journal of Medicine, 2011
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast CancerJournal of Clinical Oncology, 2009
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort studyDiabetologia, 2009
- Association Between Hyperglycemia and Survival in Patients With Newly Diagnosed GlioblastomaJournal of Clinical Oncology, 2009
- The Contribution of Malglycemia to Mortality among Allogeneic Hematopoietic Cell Transplant RecipientsTransplantation and Cellular Therapy, 2009
- Antecedent Hyperglycemia Is Associated With an Increased Risk of Neutropenic Infections During Bone Marrow TransplantationDiabetes Care, 2008